Striving to advance healthcare, broaden treatment options within the sectors of blood banking, transfusion medicine and regenerative medicine to improve patient outcomes
The Blood and Cell Technologies Company provides a wide range of products: Instruments for blood centers that separate and produce blood components for transfusions, using blood from donors; instruments used to treat patients with illnesses through cell therapy and therapeutic apheresis; and even biotech and cell processing equipment used in research institutions. As one of Terumo's three pillar companies, the Blood and Cell Technologies Company, led by a Terumo Group subsidiary in the United States, Terumo BCT*, contributes to the lives and quality of life of patients in over 130 countries and regions around the world, and to medical settings that function in the blood and cell fields.
With a spirit of collaboration with medical settings and compassion for patients, Terumo BCT pursues unique technologies to bring about better quality transfusions, blood treatments, and cell therapies.
Terumo BCT, Inc.; joined the Terumo Group in 2011
Large blood loss in accidents or surgeries
Technologies that enable safe and efficient production of blood components to bring donor blood to more patients
Treatment of blood diseases, therapeutic apheresis
Cell collection needed for treatment of leukemia, removal of disease-causing substances from blood
Cell therapy to treat cancer and other difficult diseases
Technology to wash, separate, concentrate, and cultivate cells collected from the blood of donors or the patient, to utilize cellular functions in cell therapy
Note: The regulatory approval status and availability of these products differ by country or region.
Blood Center Business
Blood from donations is processed at blood centers into products including platelets, plasma, and red blood cells, then supplied to medical institutions. Terumo provides blood centers with blood collection instruments, disposable kits, whole blood bags, and devices used to process blood products.
Whole blood collection
Blood separation and component production
Pathogen reduction technology
Therapeutic Apheresis and Cell Collection
Terumo provides a centrifugal apheresis system that separates, collects, or removes blood components. Through a variety of blood component removal therapies or collection, we provide patients with new treatment options.
This technology efficiently processes the cells needed for use in therapy and research. It is currently most used by research institutions. We sustain the development of cell therapies that have the potential to fundamentally improve healthcare.
By harnessing the potential of a patient’s own plasma, bone marrow, or adipose tissue, patients can have more treatment options. We provide the systems for separating, concentrating, and processing autologous cells in clinical settings.